Open Access

Poster Session 3 - Antiplatelet therapy

Event: ESC CONGRESS 2019
Topic: European Society of Cardiology
Session type: Poster Session
Date: 1 September 2019


5 presentations in this session

A randomized, pharmacodynamic comparison of low dose ticagrelor (60mg bid) to low dose prasugrel (5mg od) in patients with prior myocardial infarction: the ALTIC-2 study

Speaker: Doctor I. Lianos (Athens, GR)

Triple vs. double antithrombotic therapy in patients needing oral anticoagulation undergoing percutaneous coronary intervention: a meta-analysis

Speaker: Doctor D. Errigo (Turin, IT)

Combined with ticagrelor, 50 mg aspirin daily can reduce bleeding events without increasing ischaemic risk compared with 75-100 mg aspirin daily in coronary artery disease patients

Speaker: Doctor J. Li (Beijing, CN)

Bleedings during antithrombotic therapy: a blessing in disguise

Speaker: Doctor D. Cosmi (Perugia, IT)

Efficacy and safety of oral anticoagulant versus antiplatelet therapy for secondary prevention of cardiovascular disease in patients without atrial fibrillation

Speaker: Doctor F. Ricci (Chieti, IT)

5 speakers from this session

Doctor Ioannis Lianos

Attikon University Hospital, Athens (Greece)
0 follower

Doctor Daniele Errigo

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)
0 follower

Doctor Jiannan Li

Fuwai Hospital- Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (China)
0 follower

Doctor Deborah Cosmi

Gubbio-Gualdo Tadino Hospital, Perugia (Italy)
0 follower

Doctor Fabrizio Ricci

G. D'Annunzio University, Institute of Cardiology and Center of Excellence on Aging, Chieti (Italy)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk